Abstract:Background. Exosomes as extracellular vesicles (EVs) are nanoscale intercellular messengers secreted from cells to deliver biological signals. Today, exosomes have become a new field of research in regenerative medicine and are considered as potential therapies to control inflammation and wound healing and enhance and improve healing in many diseases. Given the global burden of osteoarthritis (OA) as the fastest-growing health condition and one of the major causes of physical disability in the aging population, research to establish EVs as therapeutic products can meet the basic clinical needs in the management of osteoarthritis and provide a therapeutic solution. Objectives. The present study is aimed at evaluating the regenerative potentials of the exosomes secreted from adipose and bone marrow tissue-derived mesenchymal stem cells (AD- and BM-MSCs) in ameliorating the symptoms of OA. Method. In this experimental study, AD- and BM-MSCs were isolated and cultured in the laboratory until passage 3. Finally, these cells’ secreted exosomes were isolated from their conditioned medium. Ciprofloxacin-induced OA mouse models underwent intra-articular injection of exosomes from AD-MSCs and BM-MSCs. Finally, the expression levels of collagen I and II, sox9, and aggrecan genes using real-time PCR, histological analysis, and immunohistochemical (IHC) studies were performed. Results. Real-time PCR data showed that although the expression level of collagen type II was lower in both exosome-treated groups than the normal, but it was significantly increased in comparison with the sham and OA, with higher expression in BM-Exo rather than AD-Exo group. Similarly, the histological staining and IHC results have provided almost identical data, emphasizing on better therapeutic effect of BM-MSCs-exosome than AD-MSCs-exosome. Conclusion. BM-MSCs secreted exosomes in comparison with AD-MSCs could be considered as a better therapeutic option to improve osteoarthritis and exhibit potential as a disease-modifying osteoarthritis cell-free product.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to evaluate the regenerative potential of exosomes secreted by adipose - tissue - and bone - marrow - tissue - mesenchymal stem cells (AD - MSCs and BM - MSCs) in treating a mouse model of osteoarthritis (OA). Specifically, the study aims to compare the effects of exosomes from these two sources in improving osteoarthritis symptoms, in order to determine which source of exosomes has better therapeutic potential. This not only helps to understand the biological characteristics of mesenchymal stem cell exosomes from different sources, but also provides a scientific basis for the development of exosome - based osteoarthritis treatment methods. ### Background Osteoarthritis is a degenerative and inflammatory joint disease, affecting 10% of men and 18% of women over 60 years old worldwide, bringing a huge medical burden to society. Traditional drug and non - drug treatment methods can only provide symptom relief, but cannot effectively repair damaged cartilage. Therefore, finding effective treatment methods is the focus of current research. ### Research Objectives The objective of this study is to evaluate the regenerative potential of exosomes secreted by adipose - tissue - and bone - marrow - tissue - mesenchymal stem cells (AD - MSCs and BM - MSCs) in improving osteoarthritis symptoms. ### Methods 1. **Cell Isolation and Culture**: Mesenchymal stem cells were isolated from the adipose tissue and bone marrow of volunteers and cultured in the laboratory until the third generation. 2. **Exosome Isolation**: Exosomes were isolated from the culture medium and characterized by dynamic light scattering (DLS), transmission electron microscopy (TEM), and flow cytometry. 3. **Animal Model**: A ciprofloxacin - induced mouse model of osteoarthritis was used and divided into 5 groups: healthy control group, OA control group, sham - operated group, BM - Exo group, and AD - Exo group. 4. **Treatment**: OA mice received injections of exosomes derived from BM - MSCs and AD - MSCs respectively. 5. **Evaluation**: The expression levels of collagen I and II, Sox9, and aggrecan genes were detected by real - time PCR, and the degree of cartilage damage was evaluated by histological and immunohistochemical analyses. ### Results 1. **Gene Expression**: The results of real - time PCR showed that, compared with the OA group, the expressions of Sox9, collagen II, and aggrecan genes in the AD - Exo and BM - Exo treatment groups were significantly increased, while the expression of collagen I gene was significantly decreased. 2. **Histological Analysis**: HE staining and Safranin O/Fast Green staining showed that the chondrogenesis process in the BM - Exo group was significantly improved, while the improvement effect in the AD - Exo group was relatively weak. 3. **Immunohistochemical Analysis**: IHC analysis showed that the expression of collagen II in the BM - Exo group was significantly higher than that in other groups, while the expression of collagen I in all treatment groups was low. ### Conclusion Compared with exosomes derived from AD - MSCs, exosomes derived from BM - MSCs show better therapeutic effects in improving osteoarthritis symptoms and have the potential as acellular products for treating osteoarthritis.

A Comparative Study on the Effect of Exosomes Secreted by Mesenchymal Stem Cells Derived from Adipose and Bone Marrow Tissues in the Treatment of Osteoarthritis-Induced Mouse Model

Mesenchymal stem cell-derived exosomes: a new therapeutic approach to osteoarthritis?

Comparison of exosomes secreted by induced pluripotent stem cell-derived mesenchymal stem cells and synovial membrane-derived mesenchymal stem cells for the treatment of osteoarthritis

Comparison of Bone Marrow Mesenchymal Stem Cells-Derived Exosomes, Microvesicles, and Soluble Proteins on Their Chondroprotective Effects and Therapeutic Efficacy of Osteoarthritis Treatment

Mesenchymal Stem Cell-Derived Exosomes and Their Therapeutic Potential for Osteoarthritis

Exosomes Derived from Bone Marrow Mesenchymal Stem Cells Alleviate Rheumatoid Arthritis Symptoms via Shuttling Proteins

Emerging role of mesenchymal stem/stromal cells (MSCs) and MSCs-derived exosomes in bone- and joint-associated musculoskeletal disorders: a new frontier

Effect of Exosomes From Bone Marrow–Derived Mesenchymal Stromal Cells and Adipose-Derived Stromal Cells on Bone-Tendon Healing in a Murine Rotator Cuff Injury Model

Cartilage Repair by Mesenchymal Stem Cell-Derived Exosomes: Preclinical and Clinical Trial Update and Perspectives

Enhancement of the therapeutic efficacy of mesenchymal stem cell-derived exosomes in osteoarthritis

Mesenchymal Stem Cell-Derived Exosomes as a Treatment Option for Osteoarthritis

The Therapeutic Potential of Exosomes vs. Matrix-Bound Nanovesicles from Human Umbilical Cord Mesenchymal Stromal Cells in Osteoarthritis Treatment

Therapeutic effects of bone marrow mesenchymal stem cells‐derived exosomes on osteoarthritis

Examining the Synergic Effect of Exosomes Derived from Mouse Mesenchymal Stem Cells and Low-frequency Electromagnetic Field on Chondrogenic Differentiation

Exosomes from Embryonic Mesenchymal Stem Cells Alleviate Osteoarthritis Through Balancing Synthesis and Degradation of Cartilage Extracellular Matrix

Effects of human umbilical cord mesenchymal stem cell-derived exosomes in the rat osteoarthritis models

The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes for Orthopedic Diseases Treatment

Bone marrow mesenchymal stem cell-derived exosomes protect cartilage damage and relieve knee osteoarthritis pain in a rat model of osteoarthritis

Exosomes derived from MSC as drug system in osteoarthritis therapy

Adipose mesenchymal stem cells-derived exosomes alleviate osteoarthritis by transporting microRNA -376c-3p and targeting the WNT-beta-catenin signaling axis

Research progress in the use of mesenchymal stem cells and their derived exosomes in the treatment of osteoarthritis